DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER

LOE ApproachingSM

fluconazole

NDAINJECTIONINJECTABLE
Approved
Jan 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

CLINICAL PHARMACOLOGY Pharmacokinetics and Metabolism The pharmacokinetic properties (PK) of fluconazole are similar following administration by the intravenous or oral routes. In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous…

Clinical Trials (5)

NCT00002075N/ACompleted

Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

Meningitis, CryptococcalHIV Infections
NCT00002282N/ACompleted

A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS

Candidiasis, OralHIV Infections
NCT00002132N/ACompleted

Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.

Candidiasis, EsophagealHIV Infections
NCT00001065Phase 2Completed

A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole

70 enrolled
Candidiasis, OralHIV Infections
NCT00002341N/ACompleted

A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole

Candidiasis, OralHIV Infections